FDA Rx Safety Website Will Include Drugs With Emerging Off-Label Issues
Executive Summary
FDA's "Drug Watch" website will include safety information on drugs that have emerging safety signals for off-label uses
You may also be interested in...
FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch
Despite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public
FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch
Despite FDA's decision to drop its proposed "Drug Watch" Web site, the agency will continue to make emerging drug safety information available to the public
“Drug Watch” Sent Back To The Drawing Board; FDA Turning To MedWatch?
FDA is considering proactive communication of early adverse event reports from its MedWatch monitoring system as the agency reassesses its proposed Drug Watch website for emerging safety information